Alboaggregins (AL-A, AL-B, AL-C) isolated from Trimeresurus albolabris snake venom represent a new family of proteins which bind to platelet glycoprotein lb (GPIb). These alboaggregins were purified to homogeneity with ion exchange HPLC (Mono-Q column) and hydrophobic HPLC (TSK Phenyl-5PW column). On SDS-polyacrylamide gel electrophoresis, apparent molecular weights of AL-A, AL-B and AL-C were 52 kDa, 26 kDa, and 121 kDa respectively, under nonreducing conditions. Upon reduction, each alboaggregin showed two types of chains with apparent molecular weights in the range of 15-20 kDa. All three alboaggregins agglutinated formalin-fixed platelets. Agglutination activities and binding of labeled alboaggregins to GPIb were specifically inhibited by the monoclonal antibody AK2 which is directed against the 45 kDa N-terminal region on GPIb, but not by monoclonal antibodies against other epitopes on GPIb. 125I-alboaggregin binding to platelets was not altered by the presence of thrombin. Alboaggregins did not bind to GPIIb/IIIa. Alboaggregins were competitive inhibitors for 125I-bovine vWF binding to platelets. Mutual competition studies between AL-A, AL-B and AL-C for the binding of labeled bovine vWF and AL-B to platelets demonstrated that AL-B and AL-C had a significantly higher affinity than AL-A.
References
1
Weiss HJ,
Baumgartner HR,
Tschopp TB,
Turito VT,
Cohen D.
Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood 1978; 51: 267-279
3
Read MS,
Smith SV,
Lamb MA,
Brinkhous KM.
Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor. Blood 1989; 74: 1031-1035
6
Tobelem G,
Levy-Toledano S,
Bredoux R,
Michel H,
Nurden A,
Caen J.
New approaches to determination of specific functions of platelet membrane sites. Nature (London) 1976; 263: 427-429
7
Suzuki K,
Nishioka J,
Hashimoto S.
Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor. Thromb Res 1980; 17: 215-223
12
Williams J,
Rucinski B,
Holt JC,
Niewiarowski S.
Elegantin and albolabrin purified peptides from viper venoms: homologies with the RGDS domain of fibrinogen and von Willebrand factor. Biochem Biophys Acta 1990; 1039: 81-89
15
Ganguly P,
Fossett NG.
Interaction of lentil lectin with human platelets. Evidence against glycoprotein II as aggregation mediator. Biochem Biophys Res Commun 1980; 92: 499-504
16
Ganguly P,
Fossett NG.
Evidence for multiple mechanisms of interaction between wheat germ agglutinin and human platelets. Biochem Biophys Acta 1980; 627: 256-261
18
Mascelli MA,
Edgington TS,
Kirby EP.
Characterization of a fragment of bovine von Willebrand factor that binds to platelets. Biochemistry 1986; 25: 6325-6335
19
Schagger H,
von Jagow G.
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range 1 to 100 kDa. Anal Biochem 1987; 166: 368-379
21
Fling SP,
Gregerson DS.
Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea. Anal Biochem 1986; 155: 83-88
22
Berndt MC,
Du XP,
Booth WJ.
Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1988; 27: 633-640
23
Harmon JT,
Jamieson GA.
The glycocalicin portion of platelet glycoprotein lb expresses both high and moderate affinity receptor sites for thrombin. A soluble radioreceptor assay for the interaction of thrombin with platelets. J Biol Chem 1986; 261: 13224-13229
